Why Nvidia’s $150M Baseten Bet Makes Inference the New Moat
What Changed and Why It Matters Nvidia quietly wrote a $150M check into Baseten, an AI inference platform, as part of a larger $300M round that reportedly values the company…
FDA clears wave of fetal ultrasound AI, from biometry to anomaly
What Changed and Why It Matters The FDA has cleared multiple AI tools for prenatal ultrasound. This spans routine measurements, anomaly detection, and targeted fetal heart analysis. Hospitals are now…
China’s AI Frenzy a Year After DeepSeek: Lessons for Builders
What Changed and Why It Matters DeepSeek ignited a global recalibration. Not just about benchmarks — about economics, geopolitics, and distribution. It triggered market whiplash, a flood of commentary, and…